Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Makena Enforcement Discretion, Compounding Still In Limbo Post Long-Awaited Withdrawal
Apr 06 2023
•
By
Sarah Karlin-Smith
Makena and its generics were withdrawn from the US market 5 April. • Source: Shutterstock
More from US FDA
More from Agency Leadership